English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

MicroRNA-21 (miR-21) is overexpressed virtually in all human cancers and displays oncogenic activity in a transgenic murine model. Similarly, the p53 tumor suppressor gene is the most frequently mutated gene in human cancer, and its loss or mutation leads to tumor formation in mice. To ascertain the role of miR-21 in the p53 pathwayin vivoand to characterize their interaction in tumorigenesis, we intercrossed themiR-21   −/−andTrp53   −/−mice. We found thatTrp53   −/−   miR-21   −/−mice develop tumors at a slightly later age, yet show a similar tumor spectrum and survival curve asTrp53   −/−mice. When subjected to genotoxic agents, tissues fromTrp53   −/−   miR-21   −/−mice have a higher percentage of apoptotic cells. We extracted mouse embryonic fibroblast cells (MEFs) to examine the impact of miR-21 loss on p53-regulated cellular processes inTrp53   −/−cells. Higher cellular apoptosis and senescence were found inTrp53   −/−   miR-21   −/−MEFs than inTrp53   −/−MEFs. In addition, loss of miR-21 sensitizes transformedTrp53   −/−cells to DNA damage-induced apoptosis through elevation of Pten expression. These data suggest that inhibition of miR-21 would be beneficial in apoptosis-inducing cancer therapies directed against p53-deficient tumors.

Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway